SeQuent Scientific Limited Acquires Solara Active Pharma Sciences Limited's Mahad Facility

Deepthi | Myequity news | Date : 22-09-2018 16:20:00 IST

SeQuent Scientific Limited has entered into a Business transfer agreement with Solara Active Pharma Sciences Limited to acquire the EU-GMP API facility at Mahad ( Mahad facility). The total consideration for the unit would be INR 46.4 crores on an Enterprise Valuation basis.The acquired Mahad facility compliments its current manufacturing at Vizag (USFDA approved) and Tarapur (Intermediates).


About SeQuent Scientific Limited:

SeQuent Scientific Limited is a pharmaceutical company. Its segments include Pharmaceuticals, Speciality Chemicals and Analytical Services. It focuses on products for livestock, poultry and companion animals. It also offers laboratory and technical support services. On the human health front, the Company serves the female healthcare with focus on steroids and hormones. It is operating across active pharmaceutical ingredients (API) therapeutic segments, such as anti-malarial, anthelmintics, anti-infective, antiviral, central nervous system, anti-malarial, anitbiotic, anitgout, anti-hypertensive, muscle relaxant, anti-cancer, beta-blocker, anaesthetics and dermatology. It also offers analytical and bioanalytical services to support API, pharmaceutical, personal care and nutraceutical companies.


More from Myequity